A Multicenter, Randomized, Double-blind, Placebo-controlled Parallel-group Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of XH-S004 Tablets in Patients With Non-cystic Fibrosis Bronchiectasis
Clinical trial NCT06981091 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06981091
- Sponsor
- S-INFINITY Pharmaceuticals Co., Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-16
- Primary completion
- 2027-01-08
- Enrollment
- 231
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.